The board of directors of Biolidics Limited announced the following: Mr. Chia Beng Kwan will retire as an independent director of the Company upon the conclusion of the forthcoming annual general meeting of the Company scheduled to be held on 28 April 2023. Consequently, Mr. Chia will cease to be the chairman of the nominating committee of the Company and a member of the audit committee and the remuneration committee of the Company. Ms. Ch'ng Li-Ling has been appointed as an Independent Director with effect from 31 March 2023. In accordance with Regulation 103 of the Company's constitution, Ms. Ch'ng will hold office until the
AGM where she will then be eligible for re-election as a director of the Company. Consequent to the above referred changes, as at the date of this announcement, the composition of
the Board shall be as follows: Mr. Gavin Mark McIntyre- Non-Executive Independent Chairman; Mr. Song Tang Yih- Executive Director and Chief Executive Officer; Mr. Ian David Brown, Mr. Chia Beng Kwan and Ms. Ch'ng Li-Ling as Independent Directors.